19 November 2017
News and Views
Links and Services
Biomarkers of bone formation during infliximab therapy in pediatrics Crohn’s
A trial in the latest Clinical Gastroenterology & Hepatology investigates improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease.
Crohn's disease is associated with altered bone metabolism.
Dr Meena Thayu
Clin Gastroenterol & Hepatol 2008: 6(12): 1378-84
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors